---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-004599"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:29:17.621936+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evofem issues $1.15M convertible notes to Aditxt as part of merger financing

## Summary
- Issued $1,153,846 principal in senior subordinated convertible notes and warrants to buy 74,925,075 shares to Aditxt.
- Net proceeds of ~$750,000 from partial close on April 8; Aditxt paid $650 per $1,000 principal.
- Notes bear 8% interest (12% default), mature April 8, 2028, convertible at $0.0154 per share; warrants at same price.
- Waived Aditxt default for missing $1.5M Fifth Parent Investment; second half must close by April 16 or merger can end.
- Aditxt obtained call option from Adjuvant to buy convertible notes for $13M, contingent on senior debt satisfaction.

## SEC filing metadata
- accession: 0001641172-25-004599
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000164117225004599/0001641172-25-004599-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000164117225004599/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-004599
- JSON: https://secwatch.observer/filing/0001641172-25-004599.json
- Plain text: https://secwatch.observer/filing/0001641172-25-004599.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.